Pharmacological treatment of deep brain stimulation-induced hypomania leads to clinical remission while preserving motor benefits

Neurocase

Volumn 18, Issue 2, 2012, Pages 152-159

  Schilbach, L ^a   Weiss, P H ^a,b   Kuhn, J ^a   Timmermann, L ^a   Klosterkotter J ^a   Huff, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Deep brain stimulation; Parkinson's disease; Pharmacological treatment; Positron emission tomography (PET); Stimulation induced hypomania; Subthalamic nucleus

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; CLOZAPINE; LEVODOPA; NEUROLEPTIC AGENT; ROPINIROLE; VALPROIC ACID; WATER O 15;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; DISEASE DURATION; DRUG BLOOD LEVEL; DYSKINESIA; ELECTROCARDIOGRAM; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; HOSPITALIZATION; HUMAN; HYPOKINESIA; HYPOMANIA; IDIOPATHIC PARKINSON DISEASE; INSOMNIA; INTERVENTION STUDY; MALE; MANIA; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; PARANOID PSYCHOSIS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; REMISSION; REPRODUCIBILITY; RISK FACTOR; SUBDURAL HEMATOMA; SUBTHALAMIC NUCLEUS; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; DEEP BRAIN STIMULATION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84858407567     PISSN: 13554794     EISSN: 14653656     Source Type: Journal    
DOI: 10.1080/13554794.2011.568502     Document Type: Article

References (26)

1. Appleby, B. S., Duggan, P. S., Regenberg, A. and Rabins, P. V. 2007. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Movement Disorders, 22(12): 1722-1728.
2. Aron, A. R., Behrens, T. E., Smith, S., Frank, M. J. and Poldrack, R. A. 2007. Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. Journal of Neuroscience, 27(14): 3743-3752.
3. Ballanger, B., van Eimeren, T., Moro, E., Lozano, A. M., Hamani, C.Boulinguez, P. 2009. Stimulation of the subthalamic nucleus and impulsivity: Release your horses. Annals of Neurology, 66(6): 817-824.
4. Bejjani, B. P., Damier, P., Arnulf, I., Thivard, L., Bonnet, A. M.Dormont, D. 1999. Transient acute depression induced by high-frequency deep-brain stimulation. New England Journal of Medicine, 340(19): 1476-1480.
5. Blumberg, H. P., Stern, E., Martinez, D., Ricketts, S., de Asis, J.White, T. 2000. Increased anterior cingulate and caudate activity in bipolar mania. Biological Psychiatry, 48(11): 1045-1052.
6. Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schafer, H.Botzel, K. 2006. A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine, 355(9): 896-908.
7. Eickhoff, S. B., Stephan, K. E., Mohlberg, H., Grefkes, C., Fink, G. R.Amunts, K. 2005. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage, 25(4): 1325-1335.
8. Frank, M. J., Samanta, J., Moustafa, A. A. and Sherman, S. J. 2007. Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism. Science, 318(5854): 1309-1312.
9. Gutman, D. A., Holtzheimer, P. E., Behrens, T. E., Johansen-Berg, H. and Mayberg, H. S. 2009. A tractography analysis of two deep brain stimulation white matter targets for depression. Biological Psychiatry, 65(4): 276-282.
10. Halbig, T. D., Tse, W., Frisina, P. G., Baker, B. R., Hollander, E.Shapiro, H. 2009. Subthalamic deep brain stimulation and impulse control in Parkinson's disease. European Journal of Neurology, 16(4): 493-497.
11. Hershey, T., Revilla, F. J., Wernle, A., Gibson, P. S., Dowling, J. L. and Perlmutter, J. S. 2004. Stimulation of STN impairs aspects of cognitive control in PD. Neurology, 62(7): 1110-1114.
12. Hilker, R., Voges, J., Weisenbach, S., Kalbe, E., Burghaus, L.Ghaemi, M. 2004. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: Evidence from a FDG-PET study in advanced Parkinson's disease. Journal of Cerebral Blood Flow & Metabolism, 24(1): 7-16.
13. Hirano, S., Eckert, T., Flanagan, T. and Eidelberg, D. 2009. Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease. Movement Disorders, 24(Suppl 2): S725-731.
14. Kalbe, E., Voges, J., Weber, T., Haarer, M., Baudrexel, S.Klein, J. C. 2009. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology, 72(1): 42-49.
15. Lilleeng, B. and Dietrichs, E. 2008. Unmasking psychiatric symptoms after STN deep brain stimulation in Parkinson's disease. Acta Neurologica Scandinavica Supplement, 188: 41-45.
16. Mallet, L., Schupbach, M., K, N'Diaye, Remy, P., Bardinet, E.Czernecki, V. 2007. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proceedings of the Nationall Academy of Science (USA), 104(25): 10661-10666.
17. Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D.Hamani, C. 2005. Deep brain stimulation for treatment-resistant depression. Neuron, 45(5): 651-660.
18. Okun, M. S., Fernandez, H. H., Wu, S. S., Kirsch-Darrow, L., Bowers, D.Bova, F. 2009. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE trial. Annals of Neurology, 65(5): 586-595.
19. Reck, C., Florin, E., Wojtecki, L., Krause, H., Groiss, S.Voges, J. 2009. Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's disease. European Journal of Neuroscience, 29(3): 599-612.
20. Rodrigues, A. M., Rosas, M. J., Gago, M. F., Sousa, C., Fonseca, R.Linhares, P. 2010. Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease. European Neurology, 63(3): 176-179.
21. Sesia, T., Bulthuis, V., Tan, S., Lim, L. W., Vlamings, R.Blokland, A. 2010. Deep brain stimulation of the nucleus accumbens shell increases impulsive behavior and tissue levels of dopamine and serotonin. Experimental Neurology.,
22. Soulas, T., Gurruchaga, J. M., Palfi, S., Cesaro, P., Nguyen, J. P. and Fenelon, G. 2008. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 79(8): 952-954.
23. Troster, A. I. 2009. Neuropsychology of deep brain stimulation in neurology and psychiatry. Frontiers in Bioscience, 14: 1857-1879.
24. Ulla, M., Thobois, S., Lemaire, J. J., Schmitt, A., Derost, P.Broussolle, E. 2006. Manic behaviour induced by deep-brain stimulation in Parkinson's disease: Evidence of substantia nigra implication?. Journal of Neurology, Neurosurgery & Psychiatry, 77(12): 1363-1366.
25. Ulla, M., Thobois, S., Llorca, P.M., Derost, P., Lemaire, J.J., Chereau-Boudet, I., de Chazeron, I., Schmitt, A., Ballanger, B., Broussolle, E. and Durif, F. 2010. Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: Clinical, anatomical and functional imaging study. Journal of Neurology, Neurosurgery & Psychiatry, [Epub ahead of print]
26. Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K.Schupbach, M. 2008. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain, 131: 2720-2728.